Modelling Co-Infection of the Cystic Fibrosis Lung by Pseudomonas aeruginosa and Burkholderia cenocepacia Reveals Influences on Biofilm Formation and Host Response

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Bragonzi, Alessandra ^a   Farulla, Ilaria ^b   Paroni, Moira ^a   Twomey, Kate B ^c   Pirone, Luisa ^b   Lorè, Nicola Ivan ^a   Bianconi, Irene ^a   Dalmastri, Claudia ^b   Ryan, Robert P ^c   Bevivino, Annamaria ^b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b ENEA C R CASACCIA   (Italy)

^c UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIAL IMMUNITY; BACTERIAL STRAIN; BACTERIUM CULTURE; BIOFILM; BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA INFECTION; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; LUNG FIBROSIS; LUNG INFECTION; MALE; MICROBIAL BIOMASS; MIXED INFECTION; MOUSE; NONHUMAN; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION;

ANIMALS; BIOFILMS; BURKHOLDERIA CENOCEPACIA; CYSTIC FIBROSIS; LUNG; MALE; MICE; MICE, INBRED C57BL; PSEUDOMONAS AERUGINOSA;

BACTERIA (MICROORGANISMS); BURKHOLDERIA CENOCEPACIA; MURINAE; NEGIBACTERIA; PSEUDOMONAS AERUGINOSA;

EID: 84871350905     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052330     Document Type: Article

References (46)

1. Sibley CD, Rabin H, Surette MG, (2006) Cystic fibrosis: a polymicrobial infectious disease. Future Microbiol 1: 53-61.
2. Rajan S, Saiman L, (2002) Pulmonary infections in patients with cystic fibrosis. Semin Respir Infect 17: 47-56.
3. Lipuma JJ, (2010) The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev 23: 299-323.
4. Gilligan PH, (1991) Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev 4: 35-51.
5. Govan JR, Deretic V, (1996) Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 60: 539-574.
6. Sibley CD, Duan K, Fischer C, Parkins MD, Storey DG, et al. (2008) Discerning the Complexity of Community Interactions Using a Drosophila Model of Polymicrobial Infections. PLoS Pathog 4 (10):: e1000184 doi:10.1371/journal.ppat.1000184.
7. Rogers GB, Carroll MP, Bruce KD, (2009) Studying bacterial infections through culture-independent approaches. J Med Microbiol 58: 1401-1418.
8. Stressmann FA, Rogers GB, Klem ER, Lilley AK, Donaldson SH, et al. (2011) Analysis of the bacterial communities present in lungs of patients with cystic fibrosis from American and British centers. J Clin Microbiol 49: 281-291.
9. Rogers GB, Hoffman LR, Whiteley M, Daniels TW, Carroll MP, et al. (2010) Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy. Trends Microbiol 18: 357-364.
10. Eberl L, Tummler B, (2004) Pseudomonas aeruginosa and Burkholderia cepacia in cystic fibrosis: genome evolution, interactions and adaptation. Int J Med Microbiol 294: 123-131.
11. Whiteford ML, Wilkinson JD, McColl JH, Conlon FM, Michie JR, et al. (1995) Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak. Thorax 50: 1194-1198.
12. McCloskey M, McCaughan J, Redmond AO, Elborn JS, (2001) Clinical outcome after acquisition of Burkholderia cepacia in patients with cystic fibrosis. Ir J Med Sci 170: 28-31.
13. Jones AM, Dodd ME, Govan JR, Barcus V, Doherty CJ, et al. (2004) Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis. Thorax 59: 948-951.
14. Sibley CD, Surette MG, (2011) The polymicrobial nature of airway infections in cystic fibrosis: Cangene Gold Medal Lecture. Can J Microbiol 57: 69-77.
15. Zemanick ET, Sagel SD, Harris JK, (2011) The airway microbiome in cystic fibrosis and implications for treatment. Curr Opin Pediatr 23: 319-324.
16. Zhao J, Schloss PD, Kalikin LM, Carmody LA, Foster BK, et al. (2012) Decade-long bacterial community dynamics in cystic fibrosis airways. Proc Natl Acad Sci U S A 109: 5809-5814.
17. Coggan KA, Wolfgang MC, (2012) Global regulatory pathways and cross-talk control Pseudomonas aeruginosa environmental lifestyle and virulence phenotype. Curr Issues Mol Biol 14: 47-70.
18. Vial L, Chapalain A, Groleau MC, De' ziel E, (2011) The various lifestyles of the Burkholderia cepacia complex species: a tribute to adaptation. Environ Microbiol 13: 1-12.
19. Mira NP, Madeira A, Moreira AS, Coutinho CP, Sá-Correia I, (2011) Genomic expression analysis reveals strategies of Burkholderia cenocepacia to adapt to cystic fibrosis patients' airways and antimicrobial therapy. PLoS ONE 6 (12):: e28831 doi:10.1371/journal.pone.0028831.
20. Yang L, Jelsbak L, Marvig RL, Damkiaer S, Workman CT, et al. (2011) Evolutionary dynamics of bacteria in a human host environment. Proc Natl Acad Sci USA 108: 7481-7486.
21. Hibbing ME, Fuqua C, Parsek MR, Peterson SB, (2010) Bacterial competition: surviving and thriving in the microbial jungle. Nat Rev Microbiol 8: 15-25.
22. Harrison F, (2007) Microbial ecology of the cystic fibrosis lung. Microbiology 153: 917-923.
23. Al-Bakri AG, Gilbert P, Allison DG, (2004) Immigration and emigration of Burkholderia cepacia and Pseudomonas aeruginosa between and within mixed biofilm communities. J Appl Microbiol 96: 455-463.
24. Høiby N, Ciofu O, Bjarnsholt T, (2010) Pseudomonas aeruginosa biofilms in cystic fibrosis. Future Microbiol 5: 1663-1674.
25. Coenye T, (2010) Social interactions in the Burkholderia cepacia complex: biofilms and quorum sensing. Future Microbiol 5: 1087-1099.
26. Hassett DJ, Korfhagen TR, Irvin RT, Schurr MJ, Sauer K, et al. (2010) Pseudomonas aeruginosa biofilm infections in cystic fibrosis: insights into pathogenic processes and treatment strategies. Expert Opin Ther Targets 14: 117-130.
27. Huber B, Riedel K, Hentzer M, Heydorn A, Gotschlich A, et al. (2001) The cep quorum-sensing system of Burkholderia cepacia H111 controls biofilm formation and swarming motility. Microbiology 147: 2517-2528.
28. Tomlin KL, Coll OP, Ceri H, (2001) Interspecies biofilms of Pseudomonas aeruginosa and Burkholderia cepacia. Can J Microbiol 47: 949-954.
29. Lopes SP, Ceri H, Azevedo NF, Pereira MO, (2012) Antibiotic resistance of mixed biofilms in cystic fibrosis: impact of emerging microorganisms on treatment of infection. Int J Antimicrob Agents In press. Available: http://dx.doi.org/10.1016/j.ijantimicag.2012.04.020.
30. Dalton T, Dowd SE, Wolcott RD, Sun Y, Watters C, et al. (2011) An in vivo polymicrobial biofilm wound infection model to study interspecies interactions. PLoS ONE 6 (11):: e27317 doi:10.1371/journal.pone.0027317.
31. Duan K, Dammel C, Stein J, Rabin H, Surette MG, (2003) Modulation of Pseudomonas aeruginosa gene expression by host microflora through interspecies communication. Mol Microbiol 50: 1477-1491.
32. Bragonzi A, Paroni M, Nonis A, Cramer N, Montanari S, et al. (2009) Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence. Am J Respir Crit Care Med 180: 138-145.
33. Bragonzi A, (2010) Murine models of acute and chronic lung infection with cystic fibrosis pathogens. Int J Med Microbiol 300: 584-593.
34. Stoicov C, Whary M, Rogers AB, Lee FS, Klucevsek K, et al. (2004) Coinfection modulates inflammatory responses and clinical outcome of Helicobacter felis and Toxoplasma gondii infections. J Immunol 173: 3329-3336.
35. Kosai K, Seki M, Tanaka A, Morinaga Y, Imamura Y, et al. (2011) Increase of apoptosis in a murine model for severe pneumococcal pneumonia during influenza A virus infection. Jpn J Infect Dis 64: 451-457.
36. Paroni M, Moalli F, Nebuloni M, Pasqualini F, Bonfield T, et al. (2012) Response of CFTR-deficient mice to long-term Pseudomonas aeruginosa chronic infection and PTX3 therapeutic treatment. J Infect Dis in press, published on line: October 18,doi: 10.1093/infdis/jis636.
37. Bragonzi A, Wiehlmann L, Klockgether J, Cramer N, Worlitzsch D, et al. (2006) Sequence diversity of the mucABD locus in Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Microbiology 152: 3261-3269.
38. Pirone L, Bragonzi A, Farcomeni A, Paroni M, Auriche C, et al. (2008) Burkholderia cenocepacia strains isolated from cystic fibrosis patients are apparently more invasive and more virulent than rhizosphere strains. Environ Microbiol 10: 2773-2784.
39. Bevivino A, Pirone L, Pilkington R, Cifani N, Dalmastri C, et al. (2012) Interaction of environmental Burkholderia cenocepacia strains with cystic fibrosis and non-cystic fibrosis bronchial epithelial cells in vitro. Microbiology 158: 1325-1333.
40. Hutchison ML, Poxton IR, Govan JR, (1998) Burkholderia cepacia produces a hemolysin that is capable of inducing apoptosis and degranulation of mammalian phagocytes. Infect Immun 66: 2033-2039.
41. Macho AP, Zumaquero A, Ortiz-Martin I, Beuzon CR, (2007) Competitive index in mixed infections: a sensitive and accurate assay for the genetic analysis of Pseudomonas syringae-plant interactions. Mol Plant Pathol 8: 437-450.
42. Burmølle M, Webb JS, Rao D, Hansen LH, Sørensen SJ, et al. (2006) Enhanced biofilm formation and increased resistance to antimicrobial agents and bacterial invasion are caused by synergistic interactions in multispecies biofilms. Appl Environ Microbiol 72: 3916-3923.
43. Ryan RP, Fouhy Y, Garcia BF, Watt SA, Niehaus K, et al. (2008) Interspecies signalling via the Stenotrophomonas maltophilia diffusible signal factor influences biofilm formation and polymyxin tolerance in Pseudomonas aeruginosa. Mol Microbiol 68: 75-86.
44. Ryan RP, Lucey J, O'Donovan K, McCarthy Y, Yang L, et al. (2009) HD-GYP domain proteins regulate biofilm formation and virulence in Pseudomonas aeruginosa. Environ Microbiol 11: 1126-1136.
45. van Heeckeren AM, Schluchter MD, Drumm ML, Davis PB, (2004) Role of Cftr genotype in the response to chronic Pseudomonas aeruginosa lung infection in mice. Am J Physiol Lung Cell Mol Physiol 287: L944-952.
46. Bragonzi A, Worlitzsch D, Pier GB, Timpert P, Ulrich M, et al. (2005) Nonmucoid Pseudomonas aeruginosa expresses alginate in the lungs of patients with cystic fibrosis and in a mouse model. J Infect Dis 192: 410-419.